Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer

NCT01546649 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01546649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01546649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast Cancer
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2014
Enrollment
167 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

premenopausal breast cancer